Showing results (451-460 of 658) with videos related to
Sort By:
Pageof 66
Science Translational Medicine|February 5, 2016
Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomesJoshua T Schiffer, David A Swan, Amalia Magaret, et al.Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary ResultsColleen C McLaughlin, Margaret K Doll, Kathryn T Morrison, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2017
Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ SubjectsChike O Abana, Mark A Pilkinton, Silvana Gaudieri, et al.Journal of Virology|May 29, 2015
Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2Ruchi M Newman, Susanna L Lamers, Brian Weiner, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2023
Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentationBrandon Cieniewicz, Ankit Bhatta, Damoun Torabi, et al.Frontiers in Immunology|December 13, 2019
Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector CellsLeigh Fisher, Melissa Zinter, Sherry Stanfield-Oakley, et al.The Journal of Infectious Diseases|August 1, 2013
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trialAndrew Mujugira, Amalia S Magaret, Connie Celum, et al.Viruses|October 26, 2021
Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 TransmissionDavid A Swan, Ashish Goyal, Chloe Bracis, et al.The Journal of Infectious Diseases|May 7, 2019
A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV InfectionLesia K Dropulic, Makinna C Oestreich, Harlan L Pietz, et al.Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severityRebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.Pageof 66